ASCO: You’re listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world’s leading professional organization for doctors who care for people with cancer. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so the data described here may change as research progresses. In this podcast, Dr. William Dale will discuss new research presented at the International Society of Geriatric Oncology 2020 Annual Meeting, held virtually on October 1st. Dr. Dale is director of the Center for Cancer and Aging Research at City of Hope, a comprehensive cancer center near Los Angeles. He is also the Cancer.Net Associate Editor for Geriatric Oncology. View Dr. Dale’s disclosures at Cancer.Net. ASCO would like to thank Dr. Dale for discussing this topic. Dr. Dale: Hello. Welcome to Cancer.Net. Today, I'm going to discuss research highlights presented at the 2020 International Society of Geriatric Oncology, or SIOG, Annual Meeting. I'll be discussing 2 kinds of studies. One, the rapid-fire abstracts, which were the featured abstracts in this year's virtual meeting of SIOG. And at the end, a practice-changing article that was presented. I don't have any disclosures for the rapid-fire abstracts. However, the article that was chosen for hematology to be the most relevant and practice changing this year is 1 in which I participate as a coauthor. But the majority of the work was done by others. And I will describe it when we get to that point in the discussion.    So let's jump right in. The first study is the qualitative study of a mobile health exercise intervention focused on older adults with myeloid neoplasms. So in this study, a specific intervention from the University of Rochester, a home-based exercise program referred to as GO-EXCAP was applied to older adults to help prevent the decline of physical function and side effects, primarily fatigue, in patients with multiple myeloma. This is a mobile health application which is done in the home and is largely a qualitative study with people over the age of 60. The primary findings were that this intervention was found to be especially helpful for these patients over 60. It was easily applied in the home and could be used for 5 to 30 minutes 2 to 4 times per week. Patients were starting it at the beginning of their chemotherapy. They especially liked the instructions that were provided. Found it very easy to apply and were able to engage with their family and family members during the course of using this intervention. It does involve a web portal and requires a mobile device, so people need to have those. But the activity tracker that was used, which is a common one, was provided by the team. It looks like a very promising potential intervention, knowing how important exercise is, with some caveats on the use of technology for older patients. Another study, a second study, is on the feasibility of doing a pragmatic geriatric assessment in a low-resource country, which is Brazil. So the goal of this study was not just to apply the geriatric assessment, which is known to be of importance for any older adult 65 and above with cancer, but to make it very practical and for use in an environment where you don't have all the resources you would have in an academic setting. So prior to an initial consultation, a nurse would apply the pragmatic geriatric assessment that included some very straightforward tests, ones that are recommended through the ASCO guidelines in 2018 and the SIOG guidelines that just came out. This was g